Ventyx Biosciences, Inc. (VTYX) Tops Q1 EPS by 10c

Ventyx Biosciences, Inc. (NASDAQ: VTYX) reported Q1 EPS of ($0.39), $0.10 better than the analyst estimate of ($0.49).

For earnings history and earnings-related data on Ventyx Biosciences, Inc. (VTYX) click here.

You May Also Be Interested In

• Morgan Stanley Starts Tier IV Inc (593A:JP) at Overweight
• Hanmi Pharm licenses obesity drug to Genentech in $2.3B deal
• UBS Downgrades Banco Santander Brasil SA (SANB11:BZ) (BSBR) to Neutral